These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8663052)

  • 41. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.
    Dal Farra C; Sarret P; Navarro V; Botto JM; Mazella J; Vincent JP
    Int J Cancer; 2001 May; 92(4):503-9. PubMed ID: 11304684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurotensin-metabolizing peptidases in rat fundus plasma membranes.
    Checler F; Barelli H; Kwan CY; Kitabgi P; Vincent JP
    J Neurochem; 1987 Aug; 49(2):507-12. PubMed ID: 3298547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors.
    Quehenberger O; Prossnitz ER; Cavanagh SL; Cochrane CG; Ye RD
    J Biol Chem; 1993 Aug; 268(24):18167-75. PubMed ID: 8349692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delineation of the peptide binding site of the human galanin receptor.
    Kask K; Berthold M; Kahl U; Nordvall G; Bartfai T
    EMBO J; 1996 Jan; 15(2):236-44. PubMed ID: 8617199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor.
    Chabry J; Botto JM; Nouel D; Beaudet A; Vincent JP; Mazella J
    J Biol Chem; 1995 Feb; 270(6):2439-42. PubMed ID: 7852303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible role for ligand binding of histidine 81 in the second transmembrane domain of the rat prostaglandin F2alpha receptor.
    Rehwald M; Neuschäfer-Rube F; de Vries C; Püschel GP
    FEBS Lett; 1999 Jan; 443(3):357-62. PubMed ID: 10025963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiolabeled ligands specific for the G protein-coupled state of neurotensin receptors.
    Gaudriault G; Zsürger N; Vincent JP
    J Neurochem; 1996 Dec; 67(6):2590-8. PubMed ID: 8931494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide.
    Shahrestanifar M; Wang WW; Howells RD
    J Biol Chem; 1996 Mar; 271(10):5505-12. PubMed ID: 8621408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
    Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML
    FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinct regions of C-terminus of the high affinity neurotensin receptor mediate the functional coupling with pertussis toxin sensitive and insensitive G-proteins.
    Najimi M; Gailly P; Maloteaux JM; Hermans E
    FEBS Lett; 2002 Feb; 512(1-3):329-33. PubMed ID: 11852105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B (proline-endopeptidase).
    Camargo AC; Caldo H; Emson PC
    Biochem Biophys Res Commun; 1983 Nov; 116(3):1151-9. PubMed ID: 6316969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.
    Rajotte D; Cadieux C; Haman A; Wilkes BC; Clark SC; Hercus T; Woodcock JA; Lopez A; Hoang T
    J Exp Med; 1997 Jun; 185(11):1939-50. PubMed ID: 9166423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ligand binding site of NPY at the rat Y1 receptor investigated by site-directed mutagenesis and molecular modeling.
    Robin-Jagerschmidt C; Sylte I; Bihoreau C; Hendricksen L; Calvet A; Dahl SG; Bénicourt C
    Mol Cell Endocrinol; 1998 Apr; 139(1-2):187-98. PubMed ID: 9705087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced peptide bond pseudopeptide analogues of neurotensin.
    Doulut S; Rodriguez M; Lugrin D; Vecchini F; Kitabgi P; Aumelas A; Martinez J
    Pept Res; 1992; 5(1):30-8. PubMed ID: 1623301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand.
    Pratsch G; Unfried JF; Einsiedel J; Plomer M; Hübner H; Gmeiner P; Heinrich MR
    Org Biomol Chem; 2011 May; 9(10):3746-52. PubMed ID: 21472182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.
    D'Angelo DD; Eubank JJ; Davis MG; Dorn GW
    J Biol Chem; 1996 Mar; 271(11):6233-40. PubMed ID: 8626415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs.
    Hultsch C; Pawelke B; Bergmann R; Wuest F
    Bioorg Med Chem; 2006 Sep; 14(17):5913-20. PubMed ID: 16735124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure.
    Zhang G; Wang K; Li XD; Zhang DL; Xu F
    Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A highly sensitive quantitative cytosensor technique for the identification of receptor ligands in tissue extracts.
    Lenkei Z; Beaudet A; Chartrel N; De Mota N; Irinopoulou T; Braun B; Vaudry H; Llorens-Cortes C
    J Histochem Cytochem; 2000 Nov; 48(11):1553-64. PubMed ID: 11036098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 6-Pyruvoyl tetrahydropterin synthase, an enzyme with a novel type of active site involving both zinc binding and an intersubunit catalytic triad motif; site-directed mutagenesis of the proposed active center, characterization of the metal binding site and modelling of substrate binding.
    Bürgisser DM; Thöny B; Redweik U; Hess D; Heizmann CW; Huber R; Nar H
    J Mol Biol; 1995 Oct; 253(2):358-69. PubMed ID: 7563095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.